Halozyme Therapeutics is a biopharmaceutical company that licenses its ENHANZE drug delivery technology (based on proprietary enzyme rHuPH20) to enable subcutaneous delivery of injectable biologics and small molecules. It earns royalties from ten approved partner products, markets proprietary products Hylenex and XYOSTED, and develops auto-injector devices. Recent acquisitions expanded its portfolio with Hypercon and Surf Bio hyperconcentration technologies.
expected 2026-12-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0001159036-26-000024 | EDGAR | 75K words |
| 2025-02-18 | 2024-12-31 | 0001159036-25-000010 | EDGAR | 65K words |
| 2024-02-20 | 2023-12-31 | 0001159036-24-000008 | EDGAR | 65K words |
| 2023-02-21 | 2022-12-31 | 0001159036-23-000012 | EDGAR | — |
| 2022-02-22 | 2021-12-31 | 0001159036-22-000014 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0001159036-21-000014 | EDGAR | — |
| 2020-02-24 | 2019-12-31 | 0001159036-20-000013 | EDGAR | — |
| 2019-02-21 | 2018-12-31 | 0001159036-19-000006 | EDGAR | — |
| 2018-02-20 | 2017-12-31 | 0001159036-18-000011 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001159036-17-000014 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001159036-26-000104 | EDGAR | 41K words |
| 2025-11-03 | 2025-09-30 | 0001159036-25-000045 | EDGAR | 34K words |
| 2025-08-05 | 2025-06-30 | 0001159036-25-000034 | EDGAR | 34K words |
| 2025-05-06 | 2025-03-31 | 0001159036-25-000026 | EDGAR | 30K words |
| 2024-10-31 | 2024-09-30 | 0001159036-24-000050 | EDGAR | 30K words |
| 2024-08-06 | 2024-06-30 | 0001159036-24-000044 | EDGAR | 30K words |
| 2024-05-07 | 2024-03-31 | 0001159036-24-000037 | EDGAR | 28K words |
| 2023-11-06 | 2023-09-30 | 0001159036-23-000057 | EDGAR | 55K words |
| 2023-08-08 | 2023-06-30 | 0001159036-23-000048 | EDGAR | 54K words |
| 2023-05-09 | 2023-03-31 | 0001159036-23-000039 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001159036-22-000059 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001159036-22-000050 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-22 | 0001193125-26-398015 | EDGAR | 48K words |
| 2026-09-18 | 0001159036-26-000126 | EDGAR | 2K words |
| 2026-09-16 | 0001159036-26-000121 | EDGAR | 2K words |
| 2026-08-18 | 0001159036-26-000106 | EDGAR | 1K words |
| 2026-08-06 | 0001159036-26-000103 | EDGAR | 6K words |
| 2026-03-12 | 0001159036-26-000035 | EDGAR | 1K words |
| 2026-02-17 | 0001159036-26-000023 | EDGAR | 6K words |
| 2026-01-28 | 0001159036-26-000011 | EDGAR | 3K words |
| 2025-12-09 | 0001159036-25-000070 | EDGAR | 1K words |
| 2025-12-08 | 0001159036-25-000068 | EDGAR | 1K words |
277 total filings indexed. 245 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001159036 |
| Ticker | HALO |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Headquarters | San Diego, CA |
| Website | https://www.halozyme.com |
| Listed | 2004-03-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HALO (~200 tokens, structured JSON with cryptographic provenance)